These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 32951129)
1. Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer. Karahan Şen NP; Aksu A; Kaya GÇ Ann Nucl Med; 2020 Dec; 34(12):960-967. PubMed ID: 32951129 [TBL] [Abstract][Full Text] [Related]
2. The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer. Karahan Şen NP; Alataş Ö; Gülcü A; Özdoğan Ö; Derebek E; Çapa Kaya G Nucl Med Commun; 2022 Jul; 43(7):807-814. PubMed ID: 35506284 [TBL] [Abstract][Full Text] [Related]
3. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275 [TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Lovinfosse P; Polus M; Van Daele D; Martinive P; Daenen F; Hatt M; Visvikis D; Koopmansch B; Lambert F; Coimbra C; Seidel L; Albert A; Delvenne P; Hustinx R Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):365-375. PubMed ID: 29046927 [TBL] [Abstract][Full Text] [Related]
5. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Sakin A; Sahin S; Karyagar SS; Karyagar S; Atci M; Akboru MH; Cihan S J Gastrointest Cancer; 2022 Jun; 53(2):341-347. PubMed ID: 33651265 [TBL] [Abstract][Full Text] [Related]
6. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731 [TBL] [Abstract][Full Text] [Related]
7. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012 [TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of serial Fernando S; Lin M; Pham TT; Chong S; Ip E; Wong K; Chua W; Ng W; Lin P; Lim S Br J Radiol; 2020 Jan; 93(1105):20190455. PubMed ID: 31617737 [TBL] [Abstract][Full Text] [Related]
9. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial. Guido A; Cuicchi D; Castellucci P; Cellini F; Di Fabio F; Llimpe FLR; Strigari L; Buwenge M; Cilla S; Deodato F; Macchia G; Galietta E; Golfieri R; Ardizzoni A; Zagari RM; Fanti S; Poggioli G; Fuccio L; Morganti AG Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):572-580. PubMed ID: 36127416 [TBL] [Abstract][Full Text] [Related]
11. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958 [TBL] [Abstract][Full Text] [Related]
12. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Maffione AM; Ferretti A; Grassetto G; Bellan E; Capirci C; Chondrogiannis S; Gava M; Marzola MC; Rampin L; Bondesan C; Colletti PM; Rubello D Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):853-64. PubMed ID: 23417501 [TBL] [Abstract][Full Text] [Related]
13. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer. Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180 [TBL] [Abstract][Full Text] [Related]
14. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer. Park H; Kim KA; Jung JH; Rhie J; Choi SY Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317 [TBL] [Abstract][Full Text] [Related]
15. Volumetric parameters changes of sequential 18F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. Kim SJ; Chang S Clin Nucl Med; 2015 Dec; 40(12):930-5. PubMed ID: 26204222 [TBL] [Abstract][Full Text] [Related]
16. 18 F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer. Ebinç S; Güzel Y; Oruç Z; Kömek H; Kalkan Z; Can C; Taşdemir B; Urakçi Z; Kaplan MA; Küçüköner M; Işikdoğan A Nucl Med Commun; 2023 Jan; 44(1):81-90. PubMed ID: 36437550 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation. Niccoli Asabella A; Simone M; Ballini A; Altini C; Ferrari C; Lavelli V; De Luca R; Inchingolo F; Rubini G Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8227-8236. PubMed ID: 30556862 [TBL] [Abstract][Full Text] [Related]
18. Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma. Sakane M; Tatsumi M; Hori M; Onishi H; Tsuboyama T; Nakamoto A; Ota T; Eguchi H; Wakasa K; Hatazawa J; Tomiyama N Eur J Radiol; 2017 Sep; 94():64-69. PubMed ID: 28712692 [TBL] [Abstract][Full Text] [Related]
19. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology. Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176 [TBL] [Abstract][Full Text] [Related]
20. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]